RecruitingNot ApplicableNCT03455478

Shanghai Eye Study for Adults


Sponsor

Shanghai Eye Disease Prevention and Treatment Center

Enrollment

1,000,000 participants

Start Date

Jan 1, 2016

Study Type

INTERVENTIONAL

Conditions

Summary

Blindness and visual impairment severely impact the visual health and life quality of people, particularly the 2.566 million senior citizens aged at 65 and above in Shanghai. The main reason is uncorrected refractive error, of which, 62.1% can be solved through refractive correction. For this reason, the uncorrected refractive errors of 154,000 senior citizens in Shanghai can be taken as a priority among the public health issues to prevent blindness. Now, with the aim to reduce the prevalence rate of blindness and visual impairment, it is planned to establish a public health service mechanism in terms of refractive error screening and correction for the elderly by relying on Shanghai's three-level (city-district-community) eye diseases prevention network, using proper refractive correction technology, and moving related services forward to communities in order to screen, identity, and correct blindness and visual impairment caused by refractive errors as early as possible.


Eligibility

Min Age: 18 YearsMax Age: 100 Years

Inclusion Criteria1

  • shanghai residents aged ≥18 years old

Exclusion Criteria1

  • cognitive and/or mobility disorders; non-shanghai residents; younger than 18 years old.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEspectacles

dispending spectacles for uncorrected refractive error


Locations(1)

Shanghai Eye Disease Prevention & Treatment Center

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03455478